A recent prospective cohort study found that the CHRNA5 AA genotype variant was independently associated not only with an increased risk of developing COPD and lung cancer, but also with increased smoking exposure, referred to as the ‘triple whammy effect’ [36]. Here, CHRNA5 is linked to chronic obstructive pulmonary disease.